Role of abciximab in the treatment of coronary artery disease - Wikidata - wikimedia - TriplyDB

Role of abciximab in the treatment of coronary artery disease

Role of abciximab in the treatment of coronary artery disease

http://www.wikidata.org/entity/Q28200177

about

The integrins.Aptamers as therapeutics in cardiovascular diseases.

P2860

Q36837362-60585EDC-939C-4336-8C22-88D5472DF377 Q37919102-60C2A1A8-B1FD-40EF-BBD4-D86B1F363916

P2860

Role of abciximab in the treatment of coronary artery disease

http://www.wikidata.org/entity/Q28200177

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Role of abciximab in the treatment of coronary artery disease

@ast

Role of abciximab in the treatment of coronary artery disease

@en

Role of abciximab in the treatment of coronary artery disease

@nl

type

label

Role of abciximab in the treatment of coronary artery disease

@ast

Role of abciximab in the treatment of coronary artery disease

@en

Role of abciximab in the treatment of coronary artery disease

@nl

prefLabel

Role of abciximab in the treatment of coronary artery disease

@ast

Role of abciximab in the treatment of coronary artery disease

@en

Role of abciximab in the treatment of coronary artery disease

@nl

P1433

Q28200177-92B3736F-13A5-4A9A-B5E0-490E1CCA2CB2

P1476

Q28200177-B49EF251-0B3B-4D95-A168-C4A068D2CD0C

P2093

Q28200177-2F8D627F-996D-43AF-A452-6AEBC170BA74

Q28200177-B50BF2BF-F48B-4485-AE60-0DC6C8736284

P2860

Q28200177-03E5A439-32B6-440A-B007-756309D5C888

Q28200177-052FAD89-6A06-4DE6-856D-44DBFCDAEE9C

Q28200177-0F9E04BC-B09F-4B42-8308-9BCFF8B44141

Q28200177-2947D7F0-F5EB-441A-8B3A-1B36BFE196DB

Q28200177-2AA1233C-0EC7-4C5E-9271-8DE17CB44AD8

Q28200177-30648F01-2205-48A7-8836-DA3086340054

Q28200177-31964AAA-29DB-4207-88FD-19EDD8859333

Q28200177-34D0B1D9-B9DB-4A0F-9763-9776FFBBB912

Q28200177-3C08CB3B-5060-4F68-A927-4853B4FD5675

Q28200177-42049E45-5885-4AA5-A622-36A5D8CB2424

P304

Q28200177-99B3DF12-7ACD-4FC6-A41D-1854EC31E038

P31

Q28200177-2F03AA73-486D-486D-A809-836D74108AD0

P356

Q28200177-D55181AB-BABF-4C74-9FB8-61D2783EF3DF

P407

Q28200177-699665C8-9E78-45E8-9D04-F58CA99BE606

P433

Q28200177-04991E09-3641-49D5-910C-0F7161B129F1

P478

Q28200177-A79D3F11-9103-40FC-91D1-7944C82E8354

P577

Q28200177-BD8152D4-B139-43E1-99B9-1EC898A24A1A

P698

Q28200177-42C73EBB-C9C0-4CA8-80AF-8351E55391CB

P356

14712598.6.9.935

P1433

Expert Opinion on Biological Therapy

P1476

Role of abciximab in the treatment of coronary artery disease

@en

P2093

Eduardo Infante Oliveira

http://www.w3.org/2001/XMLSchema#string

H Mesquita Gabriel

http://www.w3.org/2001/XMLSchema#string

P2860

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial

Cilostazol: a review of its use in intermittent claudication

A population-based evaluation of the thrombolysis in myocardial infarction risk score for unstable angina and non-ST elevation myocardial infarction

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Abciximab readministration: results of the ReoPro Readministration Registry

P304

935-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.6.9.935

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16918260

http://www.w3.org/2001/XMLSchema#string